The first human experiment with neural precursor cells implanted to treat chronic spinal cord injury suggests the procedure is safe, and hints at a small benefit.
A review of several dozen hospitalized patients in Brazil finds neurological conditions, including inflammation of the brain and spinal cord, in addition to Guillain-Barre syndrome.